62 related articles for article (PubMed ID: 10504451)
1. Sézary T-cell activating factor is a Chlamydia pneumoniae-associated protein.
Abrams JT; Vonderheid EC; Kolbe S; Appelt DM; Arking EJ; Balin BJ
Clin Diagn Lab Immunol; 1999 Nov; 6(6):895-905. PubMed ID: 10548583
[TBL] [Abstract][Full Text] [Related]
2. Determining the immune environment of cutaneous T-cell lymphoma lesions through the assessment of lesional blood drops.
Torii K; Okada Y; Morita A
Sci Rep; 2021 Oct; 11(1):19629. PubMed ID: 34608214
[TBL] [Abstract][Full Text] [Related]
3. CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis, yielding a target for selective cell depletion.
Papadimitriou TI; Singh P; van Caam A; Walgreen B; Gorris MAJ; Vitters EL; van Ingen IL; Koenders MI; Smeets RL; Vonk M; de Vries JM; van der Kraan PM; van Oosterhout Y; Huynen MA; Koenen HJPM; Thurlings RM
Ann Rheum Dis; 2024 Mar; 83(4):488-498. PubMed ID: 38123919
[TBL] [Abstract][Full Text] [Related]
4. Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma.
Liu X; Jin S; Hu S; Li R; Pan H; Liu Y; Lai P; Xu D; Sun J; Liu Z; Gao Y; Zhao Y; Liu F; Xiao Y; Li Y; Wen Y; Chen Z; Xu B; Lin Y; Ran M; Li Q; Yang S; Li H; Tu P; Haniffa M; Teichmann SA; Bai F; Wang Y
Nat Commun; 2022 Mar; 13(1):1158. PubMed ID: 35241665
[TBL] [Abstract][Full Text] [Related]
5. The Serine Protease CD26/DPP4 in Non-Transformed and Malignant T Cells.
Chitadze G; Wehkamp U; Janssen O; Brüggemann M; Lettau M
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885056
[TBL] [Abstract][Full Text] [Related]
6. Malignant and Benign T Cells Constituting Cutaneous T-Cell Lymphoma.
Nakai S; Kiyohara E; Watanabe R
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884736
[TBL] [Abstract][Full Text] [Related]
7. Pleomorphicskin eruptions in a COVID-19 affected patient: Case report and review of the literature.
Scala E; Fania L; Bernardini F; Calarco R; Chiloiro S; Di Campli C; Erculei S; Giani M; Giordano M; Panebianco A; Passarelli F; Trovè A; Verkhovskaia S; Russo G; Sgadari A; Didona B; Abeni D
Immun Inflamm Dis; 2021 Sep; 9(3):617-621. PubMed ID: 33942541
[TBL] [Abstract][Full Text] [Related]
8. The biomarker landscape in mycosis fungoides and Sézary syndrome.
Dulmage B; Geskin L; Guitart J; Akilov OE
Exp Dermatol; 2017 Aug; 26(8):668-676. PubMed ID: 27897325
[TBL] [Abstract][Full Text] [Related]
9. The role of 9-O-acetylated ganglioside D3 (CD60) and {alpha}4{beta}1 (CD49d) expression in predicting the survival of patients with Sezary syndrome.
Scala E; Abeni D; Pomponi D; Narducci MG; Lombardo GA; Mari A; Frontani M; Picchio MC; Pilla MA; Caprini E; Russo G
Haematologica; 2010 Nov; 95(11):1905-12. PubMed ID: 20663947
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous T-cell lymphoma: roles for chemokines and chemokine receptors.
Wu XS; Lonsdorf AS; Hwang ST
J Invest Dermatol; 2009 May; 129(5):1115-9. PubMed ID: 19242508
[TBL] [Abstract][Full Text] [Related]
11. Alpha4beta1 and alpha4beta7 CD4 T cell numbers increase and CLA CD4 T cell numbers decrease in systemic sclerosis.
Scala E; Paganelli R; Sampogna F; Abeni D; Colonna L; De Pità O; Puddu P; Russo G
Clin Exp Immunol; 2005 Mar; 139(3):551-7. PubMed ID: 15730402
[TBL] [Abstract][Full Text] [Related]
12. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
13. Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Steitz J; Roszkiewicz J; Bieber T; Tüting T
Clin Exp Dermatol; 2005 Nov; 30(6):702-6. PubMed ID: 16197392
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
16. Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7- T helper lymphocytes expansion.
Scala E; Russo G; Cadoni S; Narducci MG; Girardelli CR; De Pità O; Puddu P
J Invest Dermatol; 1999 Oct; 113(4):622-7. PubMed ID: 10504451
[TBL] [Abstract][Full Text] [Related]
17. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses.
Harmon CB; Witzig TE; Katzmann JA; Pittelkow MR
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):404-10. PubMed ID: 8784277
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
